Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
⚔️ How Monolaurin Fights Infections
1. Disrupts Lipid-Coated Microbes
Many pathogens have a fatty outer membrane (lipid envelope). Monolaurin dissolves and destabilizes this membrane, killing the microbe by:
Disrupting its cell membrane integrity
Disabling viral envelope proteins (used to infect host cells)
Inhibiting microbial communication (quorum sensing)
This method bypasses bacterial resistance mechanisms like efflux pumps or enzyme mutations that inactivate antibiotics.
🦠 Infections Monolaurin Has Been Shown to Fight
🔬 Viruses (especially enveloped viruses):
Herpes simplex (HSV-1 & HSV-2)
Cytomegalovirus (CMV)
Epstein-Barr virus (EBV)
HIV (studied for inactivation, not cure)
Influenza A and B
Measles
Coronavirus (including SARS-CoV-1)
RSV (Respiratory Syncytial Virus)
Mechanism: Dissolves viral lipid membranes and interferes with viral replication.
🧫 Antibiotic-Resistant Bacteria:
Staphylococcus aureus (including MRSA)
Streptococcus pneumoniae
Listeria monocytogenes
Helicobacter pylori
Propionibacterium acnes
Enterococcus (some VRE strains)
Mechanism: Disrupts biofilm formation, penetrates protective coatings, and neutralizes toxins.
🍄 Fungi and Yeasts:
Candida albicans (including drug-resistant strains)
Aspergillus species
Mechanism: Breaks down fungal cell membranes and interferes with replication.
🪱 Parasites (emerging evidence):
Protozoal infections like Giardia, Toxoplasma, and even Trypanosoma show some sensitivity to medium-chain fatty acids.
Anecdotal use for Lyme coinfections, mold-related illnesses, and parasites in gut biofilms.
Mechanism: Not fully understood but likely related to biofilm disruption and gut microbiome modulation.
📚 Supporting Research
Thormar et al., 1987 – Showed monolaurin’s inactivation of enveloped viruses including CMV and herpes.
Isaacs et al., 1995 (Lipids Journal) – Demonstrated bactericidal activity against Gram-positive bacteria, including resistant strains.
Carpo et al., 2007 (Journal of Medicinal Food) – Found monolaurin effective against Listeria and Staph aureus.
Lieberman et al., 2020 – Discussed monolaurin’s possible synergy with natural biofilm disruptors and gut-targeted therapies.
⚔️ How Monolaurin Fights Infections
1. Disrupts Lipid-Coated Microbes
Many pathogens have a fatty outer membrane (lipid envelope). Monolaurin dissolves and destabilizes this membrane, killing the microbe by:
Disrupting its cell membrane integrity
Disabling viral envelope proteins (used to infect host cells)
Inhibiting microbial communication (quorum sensing)
This method bypasses bacterial resistance mechanisms like efflux pumps or enzyme mutations that inactivate antibiotics.
🦠 Infections Monolaurin Has Been Shown to Fight
🔬 Viruses (especially enveloped viruses):
Herpes simplex (HSV-1 & HSV-2)
Cytomegalovirus (CMV)
Epstein-Barr virus (EBV)
HIV (studied for inactivation, not cure)
Influenza A and B
Measles
Coronavirus (including SARS-CoV-1)
RSV (Respiratory Syncytial Virus)
Mechanism: Dissolves viral lipid membranes and interferes with viral replication.
🧫 Antibiotic-Resistant Bacteria:
Staphylococcus aureus (including MRSA)
Streptococcus pneumoniae
Listeria monocytogenes
Helicobacter pylori
Propionibacterium acnes
Enterococcus (some VRE strains)
Mechanism: Disrupts biofilm formation, penetrates protective coatings, and neutralizes toxins.
🍄 Fungi and Yeasts:
Candida albicans (including drug-resistant strains)
Aspergillus species
Mechanism: Breaks down fungal cell membranes and interferes with replication.
🪱 Parasites (emerging evidence):
Protozoal infections like Giardia, Toxoplasma, and even Trypanosoma show some sensitivity to medium-chain fatty acids.
Anecdotal use for Lyme coinfections, mold-related illnesses, and parasites in gut biofilms.
Mechanism: Not fully understood but likely related to biofilm disruption and gut microbiome modulation.
📚 Supporting Research
Thormar et al., 1987 – Showed monolaurin’s inactivation of enveloped viruses including CMV and herpes.
Isaacs et al., 1995 (Lipids Journal) – Demonstrated bactericidal activity against Gram-positive bacteria, including resistant strains.
Carpo et al., 2007 (Journal of Medicinal Food) – Found monolaurin effective against Listeria and Staph aureus.
Lieberman et al., 2020 – Discussed monolaurin’s possible synergy with natural biofilm disruptors and gut-targeted therapies.